SANJIVANI PARANTERAL LTD. Share Price

SANJIVANI PARANTERAL LTD. Share Price

BSE: 531569
|
Pharmaceuticals
₹ 149.00
-₹1.05 (-0.7%)
1D
Last updated 24 Jul, 2026, 15:26 IST

SANJIVANI PARANTERAL LTD. Share Price Today

As of 25 Jul 2026, SANJIVANI PARANTERAL LTD. share price is ₹149.00. The stock opened at ₹152.95, compared to its previous close of ₹150.05. During today's trading session, SANJIVANI PARANTERAL LTD. share price moved in the range of ₹147.90 to ₹152.95, with an average price of ₹150.43 for the day. Looking at its last 52-week, the stock has touched a low of ₹126.00 and a high of ₹268.80.

₹147.90
0.70% down today
₹152.95
1D LOW
1D HIGH

SANJIVANI PARANTERAL LTD. Returns Calculator

Circuit
L
H
₹118.95
₹178.35
52-week
L
H
₹126.00
₹268.80
Mkt Cap Cr
184.33
P/E
27.28
P/B
3.79
ROE
13.87%
D/E
0.19
ROCE
16.29%
Div. Yield
0.00%
EPS(TTM)
5.67
Turnover
1.14
EV/EBITDA
17.32
Net Margin
0.00%
Op. Margin
0.00%
ROA
7.62%
Quick Ratio
0.00
Curr. Ratio
2.53
Based on fundamentals, this stock's
Step 3 of 5
Performance
Neutral
Sanjiv.Parant. performance is moderate compared to markets
Step 1 of 5
Valuation
Overvalued
Sanjiv.Parant. appears overvalued compared to its peers
Step 1 of 5
Earnings
Very Poor
Sanjiv.Parant. revenue, operating profits and net profits have been degrowing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,65,711.0036.735.0514.85%0.5518.72%18.850.91%0.5610.90
Divis Laboratories1,93,860.0061.369.4016.19%0.0021.00%9.430.50%0.5898.19
Torrent Pharmaceuticals1,92,687.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,12,593.0033.553.2711.27%0.0014.95%423.360.93%0.4443.52
Zydus Lifesciences1,11,082.0017.393.2319.69%0.3520.30%3.700.11%0.3935.38
Lupin1,09,553.0019.834.7127.01%0.0327.44%3.510.78%0.61129.18
Mankind Pharma1,03,472.001.050.1212.65%0.4212.97%5.050.05%0.5449.37
Dr. Reddy's Laboratories96,204.7030.222.5311.07%0.1812.54%377.960.69%0.4138.68
Aurobindo Pharma88,508.4025.272.349.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs84,727.3060.2610.1018.21%0.4016.70%97.210.12%0.6413.72

SANJIVANI PARANTERAL LTD. Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024
Revenue₹70.10₹54.41
Other Income₹1.21₹0.52
Total Revenue₹71.31₹54.93
Total Expenses₹60.96₹47.36
Profit Before Tax₹10.35₹7.57
Tax₹2.26₹1.41
Profit After Tax₹8.09₹6.17
EPS - Basic₹6.81₹5.28
EPS - Diluted₹6.81₹5.28

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024
Profit before tax₹10.35₹7.57
Income before WC changes₹11.08₹8.34
Change in Assets-₹12.07-₹10.59
Change in Liabilities₹14.71-₹7.34
Change in WC₹2.64-₹17.93
Cash flow from Operations₹12.40-₹10.70
Cash flow from Investing-₹21.91-₹12.21
Cash flow from Financing₹10.46₹23.16
Total Cash Flow₹0.94₹0.24
Cash (Start of the year)₹0.54₹0.30
Cash (End of the year)₹1.49₹0.54

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024
Non-Current Assets₹44.02₹14.77
Current Assets₹34.18₹28.64
Total Assets₹78.20₹43.41
Current Liabilities₹31.79₹13.78
Net Current Asset₹2.39₹14.86
Non-Current Liabilities₹6.53₹1.73
Equity Capital₹39.87₹27.90
Total Equity & Liabilities₹78.20₹43.41

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹70.10₹54.41₹35.49₹30.61
Other Income₹1.21₹0.52₹0.55₹0.24
Total Revenue₹71.31₹54.93₹36.05₹30.86
Total Expenses₹60.95₹47.36₹31.10₹25.98
Profit Before Tax₹10.36₹7.57₹4.94₹4.88
Tax₹2.26₹1.41₹0.43₹0.03
Profit After Tax₹8.10₹6.17₹4.51₹4.85
EPS - Basic₹6.89₹5.28₹4.51₹4.85
EPS - Diluted₹6.67₹5.28₹4.51₹4.85

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹10.36₹7.57₹4.94₹4.88
Income before WC changes₹11.09₹8.34₹5.63₹4.35
Change in Assets-₹15.90-₹10.59-₹3.15₹2.42
Change in Liabilities₹5.90-₹7.34₹2.25₹1.79
Change in WC-₹10.00-₹17.93-₹0.90₹4.22
Cash flow from Operations-₹0.24-₹10.70₹4.68₹8.52
Cash flow from Investing-₹5.81-₹12.21-₹0.99-₹0.67
Cash flow from Financing₹6.14₹23.16-₹3.73-₹7.68
Total Cash Flow₹0.09₹0.24-₹0.04₹0.17
Cash (Start of the year)₹0.54₹0.30₹0.34₹0.17
Cash (End of the year)₹0.63₹0.54₹0.30₹0.34

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹26.89₹14.77₹12.74₹10.57
Current Assets₹38.10₹28.64₹8.27₹7.73
Total Assets₹65.00₹43.41₹21.01₹18.30
Current Liabilities₹20.46₹13.78₹22.65₹21.89
Net Current Asset₹17.64₹14.86-₹14.39-₹14.17
Non-Current Liabilities₹6.53₹1.73₹1.43₹3.99
Equity Capital₹38.00₹27.90-₹3.07-₹7.58
Total Equity & Liabilities₹65.00₹43.41₹21.01₹18.30
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
2
Neutral
5
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
54.26
Neutral
ATR (14)
8.24
Neutral
STOCH(9,6)
29.56
Neutral
STOCH RSI (14)
100
Bearish
ADX(9)
35.35
Bearish
UO(9)
39.36
Neutral
ROC(12)
2.77
Bullish
WillR(14)
-70.44
Neutral
Period
Simple value
Exponential vaue
5D
147.67
147.6
10D
145.25
146.75
20D
147.44
146.88
50D
146.24
149.76
100D
156.04
158.07

About SANJIVANI PARANTERAL LTD.

SANJIVANI PARANTERAL LTD. Share Price
ISIN
INE860D01013
Sector Market Cap
₹ 184.33 Cr

Sanjivani Paranteral Limited is engaged in the business of manufacturing pharmaceutical products. The Company’s products include oral solids, small volume parenteral and sterile powder formula. Its product category includes antibiotic, anti-emetic, non-steroidal anti-inflammatory drugs (NSAID) and analgesic, antimalarial, calcium and vitamin, sedative, steroid, cardiovascular, anti-fibrinolytic, anti-coagulant, vasoconstrictor, inotropic agent, multivitamin, nutrition, diuretic, anti-hypertensive, and others. Its anti-biotic includes Netilmicin Sulfate, Amikacin Sulfate, and Gentamycin Sulfate. Its anti-emetic includes Ranitidine Hydrochloride, Metoclopramide, Ondansetron, and Promethazine. Its NSAID and analgesic include Acetaminophen Injection and Diclofenac Sodium Injection. Its calcium and vitamins include Methylcobalamin 500 mcg/ml and Nicotinic Acid 10 mg/ml. Its sedative includes Midazolam Hydrochloride, and Diazepam. Its diuretic includes Furosemide.

SANJIVANI PARANTERAL LTD. Financial Highlights

  • Revenue: SANJIVANI PARANTERAL LTD. reported revenue of ₹69.76 crore in FY26 vs ₹71.32 crore in FY25. It showed a decrease of 2.19% on a yearly basis.
  • Operating Profit: SANJIVANI PARANTERAL LTD. reported an operating profit of ₹9.39 crore in FY26 vs ₹10.35 crore in FY25. It showed a decrease of 9.28% on a year-on-year basis.
  • Net Profit: SANJIVANI PARANTERAL LTD. reported a net profit of ₹6.69 crore in FY26 vs ₹8.09 crore in FY25. It showed a decrease of 17.31% on a yearly basis.

SANJIVANI PARANTERAL LTD. Quarterly Result Highlights

  • SANJIVANI PARANTERAL LTD. reported revenue of ₹13.81 crore in Mar 2026, compared with ₹22.36 crore in Dec 2025, representing a decrease of 38.24% on a quarter-on-quarter (QoQ) basis.
  • SANJIVANI PARANTERAL LTD. reported an operating profit of ₹1.20 crore in Mar 2026, compared with ₹3.70 crore in Dec 2025, representing a decrease of 67.57% on a quarter-on-quarter (QoQ) basis.
  • SANJIVANI PARANTERAL LTD. reported a profit of ₹0.55 crore in Mar 2026, compared with ₹2.78 crore in Dec 2025, reflecting a decrease of 80.22% on a QoQ basis.
  • The earnings per share (EPS) of SANJIVANI PARANTERAL LTD. stood at ₹6.81 during Mar 2026.
Know more
Promoters
31.56%
FII
0.00%
Other DII
5.45%
Retail and other
62.98%
Mutual funds
0.00%
Foreign institutions - FII
Compare against other stocks
SANJIVANI PARANTERAL LTD. Share Price
SANJIVANI PARANTERAL LTD.
Pharmaceuticals
Add Stock
Add Another

FAQs on SANJIVANI PARANTERAL LTD. Share Price